NASDAQ:DARA - DARA Biosciences Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $0.31 +0.31 (+∞) (As of 07/19/2018 06:00 AM ET)Previous CloseN/AToday's Range$0.31 - $0.3152-Week Range$0.67 - $1.05Volume1,000 shsAverage Volume118,843 shsMarket Capitalization$17.38 millionP/E RatioN/ADividend YieldN/ABeta0.72 Company ProfileFinancialsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company's primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc. Receive DARA News and Ratings via Email Sign-up to receive the latest news and ratings for DARA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A SymbolNASDAQ:DARA CUSIPN/A Webwww.darabiosciences.com Phone+1-816-9147027 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-228.42% Return on Equity-145.61% Return on Assets-100.38% Miscellaneous EmployeesN/A Outstanding Shares19,760,000Market Cap$17.38 DARA Biosciences (NASDAQ:DARA) Frequently Asked Questions What is DARA Biosciences' stock symbol? DARA Biosciences trades on the NASDAQ under the ticker symbol "DARA." How were DARA Biosciences' earnings last quarter? DARA Biosciences Inc (NASDAQ:DARA) posted its earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.14). The specialty pharmaceutical company earned $1.18 million during the quarter, compared to the consensus estimate of $0.83 million. DARA Biosciences had a negative return on equity of 145.61% and a negative net margin of 228.42%. View DARA Biosciences' Earnings History. What is the consensus analysts' recommendation for DARA Biosciences? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DARA Biosciences in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has DARA Biosciences been receiving favorable news coverage? Headlines about DARA stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. DARA Biosciences earned a media sentiment score of 0.13 on Accern's scale. They also assigned media stories about the specialty pharmaceutical company an impact score of 46.38 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. How do I buy shares of DARA Biosciences? Shares of DARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is DARA Biosciences' stock price today? One share of DARA stock can currently be purchased for approximately $0.31. How big of a company is DARA Biosciences? DARA Biosciences has a market capitalization of $17.38 million. How can I contact DARA Biosciences? DARA Biosciences' mailing address is 8601 Six Forks Rd Ste 160, RALEIGH, NC 27615-2965, United States. The specialty pharmaceutical company can be reached via phone at +1-816-9147027. MarketBeat Community Rating for DARA Biosciences (NASDAQ DARA)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 77 (Vote Outperform)Underperform Votes: 56 (Vote Underperform)Total Votes: 133MarketBeat's community ratings are surveys of what our community members think about DARA Biosciences and other stocks. Vote "Outperform" if you believe DARA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DARA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: What are CEFs?